Physical Exercise and the Hallmarks of Breast Cancer: A Narrative Review.
biomarkers
breast cancer
mammary cancer
physical activity
training
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
03 Jan 2023
03 Jan 2023
Historique:
received:
16
11
2022
revised:
26
12
2022
accepted:
27
12
2022
entrez:
8
1
2023
pubmed:
9
1
2023
medline:
9
1
2023
Statut:
epublish
Résumé
Growing evidence suggests that, among the different molecular/cellular pathophysiological mechanisms associated with cancer, there are 14 hallmarks that play a major role, including: (i) sustaining proliferative signaling, (ii) evading growth suppressors, (iii) activating invasion and metastasis, (iv) enabling replicative immortality, (v) inducing angiogenesis, (vi) resisting cell death, (vii) reprogramming energy metabolism, (viii) evading immune destruction, (ix) genome instability and mutations, (x) tumor-promoting inflammation, (xi) unlocking phenotypic plasticity, (xii) nonmutational epigenetic reprogramming, (xiii) polymorphic microbiomes, and (xiv) senescent cells. These hallmarks are also associated with the development of breast cancer, which represents the most prevalent tumor type in the world. The present narrative review aims to describe, for the first time, the effects of physical activity/exercise on these hallmarks. In summary, an active lifestyle, and particularly regular physical exercise, provides beneficial effects on all major hallmarks associated with breast cancer, and might therefore help to counteract the progression of the disease or its associated burden.
Identifiants
pubmed: 36612320
pii: cancers15010324
doi: 10.3390/cancers15010324
pmc: PMC9818971
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Med Sci Sports Exerc. 2021 Mar 1;53(3):496-504
pubmed: 32910094
Breast Cancer Res Treat. 2012 May;133(1):127-35
pubmed: 21837478
Breast Cancer Res. 2014 Apr 14;16(2):R39
pubmed: 24731917
Cancer Prev Res (Phila). 2013 Sep;6(9):925-37
pubmed: 23842792
Med Sci Sports Exerc. 2010 Jul;42(7):1409-26
pubmed: 20559064
Med Sci Sports Exerc. 2020 Jul;52(7):1470-1476
pubmed: 31977642
Cancers (Basel). 2020 Jan 08;12(1):
pubmed: 31936342
Cytokine Growth Factor Rev. 2017 Dec;38:80-97
pubmed: 29158066
Breast Cancer Res. 2012 Feb 07;14(1):R23
pubmed: 22314082
Perm J. 2020;24:
pubmed: 32589577
J Cancer. 2016 Jun 23;7(10):1281-94
pubmed: 27390604
Front Oncol. 2020 Oct 28;10:577420
pubmed: 33194695
Eur J Cancer Care (Engl). 2013 Sep;22(5):626-37
pubmed: 23731173
Breast Cancer (Auckl). 2017 Nov 24;11:1178223417743976
pubmed: 29434469
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
BMC Genomics. 2017 Nov 14;18(Suppl 8):802
pubmed: 29143608
Int J Mol Sci. 2019 Oct 06;20(19):
pubmed: 31590453
Trends Mol Med. 2019 Jul;25(7):595-611
pubmed: 31078431
Trends Cancer Res. 2016 Jan 1;11(1):1-27
pubmed: 27928197
Breast Cancer Res Treat. 2016 Feb;155(3):471-82
pubmed: 26820653
Breast Cancer Res Treat. 2012 Nov;136(2):331-45
pubmed: 23073759
Br J Cancer. 2009 Mar 24;100(6):865-9
pubmed: 19240721
Rejuvenation Res. 2015 Feb;18(1):57-89
pubmed: 25431878
Biomolecules. 2021 Jan 19;11(1):
pubmed: 33477996
Health Qual Life Outcomes. 2020 Oct 12;18(1):338
pubmed: 33046106
Cancer Res. 2020 Jan 1;80(1):116-125
pubmed: 31578201
Iran J Basic Med Sci. 2014;17(4):231-58
pubmed: 24904714
Cytokine. 2019 Aug;120:155-164
pubmed: 31085453
Med Hypotheses. 2010 Aug;75(2):192-5
pubmed: 20219289
Epidemiol Rev. 2017 Jan 1;39(1):71-92
pubmed: 28453622
Front Cell Dev Biol. 2021 Mar 22;9:641449
pubmed: 33829018
J Cancer Res Clin Oncol. 2019 Oct;145(10):2583-2593
pubmed: 31401675
Med Sci Sports Exerc. 2005 Nov;37(11):1827-35
pubmed: 16286849
Cell Metab. 2018 Jan 9;27(1):10-21
pubmed: 29056514
Clin Obstet Gynecol. 2016 Dec;59(4):651-672
pubmed: 27681694
In Vivo. 2018 Mar-Apr;32(2):249-254
pubmed: 29475906
J Exp Clin Cancer Res. 2011 Sep 26;30:87
pubmed: 21943236
Trends Cancer. 2017 Jan;3(1):56-71
pubmed: 28718426
Appl Physiol Nutr Metab. 2011 Aug;36(4):533-8
pubmed: 21851206
Phys Act Nutr. 2020 Sep;24(3):25-31
pubmed: 33108715
Acta Histochem. 2016 Jun;118(5):544-52
pubmed: 27246286
PLoS One. 2013 Nov 27;8(11):e80123
pubmed: 24312199
Trends Biochem Sci. 2016 Mar;41(3):211-218
pubmed: 26778478
Biol Direct. 2010 Apr 20;5:22
pubmed: 20406440
Br J Cancer. 2014 Oct 28;111(9):1718-25
pubmed: 25144625
Med Sci Sports Exerc. 2009 Aug;41(8):1597-605
pubmed: 19568200
Br J Cancer. 2018 Jul;119(2):141-152
pubmed: 29867226
Front Oncol. 2021 Mar 11;11:652266
pubmed: 33777815
Nat Med. 2019 Mar;25(3):377-388
pubmed: 30842679
J Clin Oncol. 2008 Feb 20;26(6):907-12
pubmed: 18281663
Cancer Nurs. 2018 Jul/Aug;41(4):E31-E38
pubmed: 28727578
Breast Cancer Res Treat. 2018 Sep;171(2):247-259
pubmed: 29948402
J Adv Pharm Technol Res. 2010 Apr;1(2):109-26
pubmed: 22247839
J Physiol. 2015 Jun 15;593(12):2635-48
pubmed: 25907793
Wiley Interdiscip Rev Syst Biol Med. 2017 Mar;9(2):
pubmed: 27943646
Int J Exp Pathol. 2017 Feb;98(1):40-46
pubmed: 28556395
Cancers (Basel). 2022 Aug 05;14(15):
pubmed: 35954474
Cells. 2019 Jan 31;8(2):
pubmed: 30709063
Breast. 2017 Jun;33:166-177
pubmed: 28415013
Asian Pac J Cancer Prev. 2015;16(6):2129-44
pubmed: 25824729
Exp Physiol. 2016 Jan;101(1):28-32
pubmed: 26391197
Cytokine. 2011 Aug;55(2):274-9
pubmed: 21600785
World J Clin Oncol. 2014 Aug 10;5(3):283-98
pubmed: 25114845
Cancer. 2003 Apr 1;97(7):1746-57
pubmed: 12655532
Nurs Forum. 2019 Jan;54(1):45-52
pubmed: 30332516
Eur J Breast Health. 2018 Apr 01;14(2):64-71
pubmed: 29774312
Exp Physiol. 2018 Feb 1;103(2):222-235
pubmed: 29143998
Niger Med J. 2013 Nov;54(6):371-5
pubmed: 24665149
Br J Cancer. 2021 Aug;125(3):324-336
pubmed: 33828258
Breast Cancer Res Treat. 2018 Feb;168(1):147-157
pubmed: 29168064
Semin Cancer Biol. 2015 Dec;35 Suppl:S55-S77
pubmed: 25749195
Int J Cardiol. 2014 Feb 1;171(2):e50-1
pubmed: 24365613
Cytokine Growth Factor Rev. 2009 Jun;20(3):193-201
pubmed: 19520599
Cells. 2020 Mar 05;9(3):
pubmed: 32151035
Biomedicines. 2022 Oct 08;10(10):
pubmed: 36289773
Methods Mol Biol. 2015;1238:425-66
pubmed: 25421674
Biomed Pharmacother. 2016 Jul;81:273-280
pubmed: 27261604
Int J Behav Med. 2011 Dec;18(4):333-41
pubmed: 21336679
Oncotarget. 2017 Jul 4;8(27):45008-45019
pubmed: 28410238
Br J Cancer. 2021 Jul;125(2):164-175
pubmed: 33824479
Cancer Res. 2017 Sep 15;77(18):4894-4904
pubmed: 28887324
Int J Sports Med. 1995 Jul;16(5):334-7
pubmed: 7558532
Int J Cancer. 2015 Feb 15;136(4):E197-202
pubmed: 25124080
Cancer Causes Control. 2015 Mar;26(3):333-44
pubmed: 25579073
Cancers (Basel). 2020 Jul 06;12(7):
pubmed: 32640718
Am J Physiol Endocrinol Metab. 2011 Sep;301(3):E504-10
pubmed: 21653222
Integr Cancer Ther. 2013 Jul;12(4):323-35
pubmed: 22831916
Clin Breast Cancer. 2017 Oct;17(6):408-417
pubmed: 28606800
Exerc Immunol Rev. 2012;18:158-76
pubmed: 22876727
Cancer Cell Int. 2021 Jan 20;21(1):62
pubmed: 33472628
Int J Biol Sci. 2017 Nov 1;13(11):1387-1397
pubmed: 29209143
Mol Cell Endocrinol. 2014 Jan 25;382(1):673-682
pubmed: 23791814
Cancers (Basel). 2020 Aug 11;12(8):
pubmed: 32796499
J Cancer Res Ther. 2014 Jul-Sep;10(3):506-11
pubmed: 25313729
Cancers (Basel). 2021 Aug 03;13(15):
pubmed: 34359821
Oncotarget. 2020 Jan 28;11(4):452-461
pubmed: 32064049
Ann Phys Rehabil Med. 2019 Sep;62(5):329-335
pubmed: 31400480
In Vivo. 2020 Mar-Apr;34(2):495-501
pubmed: 32111746
Cancers (Basel). 2021 Aug 30;13(17):
pubmed: 34503198
J Clin Oncol. 2012 Jul 10;30(20):2530-7
pubmed: 22614980
Phys Ther. 2018 Nov 1;98(11):946-952
pubmed: 30388254
Expert Rev Mol Diagn. 2018 Mar;18(3):227-243
pubmed: 29424261
Microorganisms. 2022 Aug 27;10(9):
pubmed: 36144329
Signal Transduct Target Ther. 2016 Jan 28;1:15004
pubmed: 29263891
J Breast Cancer. 2020 Mar 26;23(2):205-217
pubmed: 32395379
Exp Cell Res. 2011 May 1;317(8):1108-18
pubmed: 21356207
Trends Cancer. 2017 Jun;3(6):423-441
pubmed: 28718417
Braz J Med Biol Res. 2018 Jan 23;51(3):1-7
pubmed: 29513878
Curr Biol. 2020 Aug 17;30(16):R921-R925
pubmed: 32810447
Front Mol Biosci. 2022 Sep 08;9:930361
pubmed: 36158576
Cancer Epidemiol Biomarkers Prev. 2008 Aug;17(8):1920-9
pubmed: 18708381
PLoS One. 2014 Feb 14;9(2):e86990
pubmed: 24551047
Onco Targets Ther. 2020 May 19;13:4423-4430
pubmed: 32547073
BMC Cancer. 2015 Nov 11;15:898
pubmed: 26560078
Int J Mol Sci. 2020 Dec 03;21(23):
pubmed: 33287442
J Cancer Res Clin Oncol. 2018 Mar;144(3):579-586
pubmed: 29305709
Support Care Cancer. 2017 May;25(5):1563-1570
pubmed: 28064384
Genes Dis. 2018 May 12;5(2):77-106
pubmed: 30258937
Cancers (Basel). 2021 Aug 17;13(16):
pubmed: 34439282
Int J Radiat Oncol Biol Phys. 2016 Feb 1;94(2):329-37
pubmed: 26853341
J Appl Physiol (1985). 2005 Apr;98(4):1534-40
pubmed: 15772062
Oxid Med Cell Longev. 2018 Sep 30;2018:5896786
pubmed: 30363988
Exp Biol Med (Maywood). 2015 Nov;240(11):1408-15
pubmed: 25990440
Eur J Breast Health. 2017 Jul 01;13(3):103-112
pubmed: 28894848
Integr Cancer Ther. 2020 Jan-Dec;19:1534735420949678
pubmed: 32909498
Medicine (Baltimore). 2018 Apr;97(17):e0524
pubmed: 29703023
J Natl Cancer Inst. 2015 Mar 16;107(5):
pubmed: 25780062
J Appl Physiol (1985). 2010 Feb;108(2):343-8
pubmed: 19959769
Cell. 2000 Jan 7;100(1):57-70
pubmed: 10647931
Sports Med Open. 2022 Mar 4;8(1):36
pubmed: 35244811
Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):306-13
pubmed: 19124513
Cancer Prev Res (Phila). 2013 Feb;6(2):109-18
pubmed: 23213072
Cell Physiol Biochem. 2018;51(6):2647-2693
pubmed: 30562755
Oncotarget. 2019 Oct 15;10(57):6021-6037
pubmed: 31666932
Life Sci. 2016 Apr 15;151:30-40
pubmed: 26924493
J Acad Nutr Diet. 2020 Apr;120(4):650-659
pubmed: 30420171
Cancer Cell. 2008 Jun;13(6):472-82
pubmed: 18538731
Mol Oncol. 2010 Jun;4(3):255-66
pubmed: 20434415
J Med Life. 2015;8(Spec Iss 4):6-11
pubmed: 28316699
Cancers (Basel). 2022 Apr 08;14(8):
pubmed: 35454797
Cancer Discov. 2022 Jan;12(1):31-46
pubmed: 35022204
Oncol Lett. 2018 Jan;15(1):41-47
pubmed: 29285186
Breast Cancer Res Treat. 2012 Feb;131(3):791-800
pubmed: 21452021
J Cancer. 2020 May 18;11(15):4474-4494
pubmed: 32489466
J Clin Oncol. 2018 Mar 20;36(9):875-883
pubmed: 29356607
Cell Adh Migr. 2010 Jul-Sep;4(3):358-62
pubmed: 20418665
Dev Cell. 2021 May 17;56(10):1363-1393
pubmed: 33945792
J Natl Cancer Inst. 2021 Jan 4;113(1):54-63
pubmed: 32239145
Breast Cancer Res. 2014 Sep 28;16(5):446
pubmed: 25467785
Exerc Sport Sci Rev. 2019 Apr;47(2):75-85
pubmed: 30883471
Gac Med Mex. 2015 Jul-Aug;151(4):491-500
pubmed: 26290026
Cancer Treat Rev. 2018 Nov;70:98-111
pubmed: 30130687
Breast Cancer Res. 2017 Feb 21;19(1):19
pubmed: 28222775
Breast Cancer Res Treat. 2018 Nov;172(1):105-112
pubmed: 30062572
Am J Cancer Res. 2017 Sep 01;7(9):1926-1936
pubmed: 28979814
Cancers (Basel). 2020 Jun 10;12(6):
pubmed: 32532068
Clin Cancer Res. 2016 Oct 1;22(19):4766-4775
pubmed: 27407093
Support Care Cancer. 2022 Dec;30(12):10323-10334
pubmed: 36322246
J Zhejiang Univ Sci B. 2015 Jan;16(1):32-43
pubmed: 25559953
Breast Cancer (Dove Med Press). 2019 Apr 10;11:151-164
pubmed: 31040712
Cells. 2020 May 20;9(5):
pubmed: 32443727
Adv Pharm Bull. 2019 Jun;9(2):205-218
pubmed: 31380246
Cells. 2020 Dec 06;9(12):
pubmed: 33291355
Curr Obes Rep. 2019 Dec;8(4):413-433
pubmed: 31637624
Radiol Oncol. 2021 Jan 12;55(1):7-17
pubmed: 33885236